about
Development of a method for the determination of vardenafil in human plasma by high performance liquid chromatography with UV detection.A high performance liquid chromatographic procedure for the simultaneous determination of norfloxacin and furprofen in rat plasma.[Non-steroidal anti-inflammatory agents. III. Synthesis and analgesic-anti-inflammatory activity of 4-(pyrrol-1-yl)phenylacetamides and 4-(pyrrol-1-yl)phenethylamines]Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic intestinal biopsy samples in humans by high-performance liquid chromatography with electrochemical detection.Mesalazine vanishing time from rectal mucosa following its topical administration.N-Butyrate rectal transport in cirrhotic patients.Chronic atrophic gastritis and risk of N-nitroso compounds carcinogenesis.Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma.Neurochemical and behavioural effects of chronic aldicarb administration in rats.Pain during injection and venous sequelae: thiopentone versus propofol.Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?Melphalan hypoxic perfusion with hemofiltration for melanoma locoregional metastases in the pelvis.Effects of maternal exposure to polychlorobiphenyls (PCBs) on F1 generation behavior in the rat.Diaper dermatitis: a study of contributing factorsAnalytical procedure for the determination of rufloxacin, a new pyridobenzothiazine, in human serum and urine by high-performance liquid chromatographyDetermination of rufloxacin, a new tricyclic fluoroquinolone in biological fluids using high-performance liquid chromatography with ultraviolet detectionDetermination of furprofen in human plasma by solid-phase extraction and reversed-phase high-performance liquid chromatography[Nonsteroidal anti-inflammatory agents. V. Synthesis of 1-aryl-5-(1-pyrryl)-pyrazolyl-4-acetic acids with potential anti-inflammatory action]Rufloxacin, a new fluoroquinolone in biological fluids by high-performance liquid chromatographyQuantitation of the enantiomers of furprofen in biological fluids by high-performance liquid chromatography[Heterocyclic systems. IV. Synthesis and CNS activity of derivatives of 4H,6H-pyrrolo[1,2-a][4,1]-benzoxazepine][Heterocyclic systems. V. Synthesis and CNS activity of derivatives of 6H-pyrrolo (1,2-a) (1,4)-benzodiazepine]Simultaneous determination of rufloxacin and theophylline by high-performance liquid chromatography in human plasmaSimultaneous determination of rufloxacin, fenbufen and felbinac in human plasma using high-performance liquid chromatography[Therapeutic monitoring of drugs]Pharmacokinetic of intraarterial mitomycin C with extra corporeal detoxification in humansRectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatmentBehavioral effects of PCBs in miceSignificance of duplex/colour Doppler sonography in hepatic arterial chemotherapy for patients with liver metastases from colorectal carcinomaAnastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del RettoSimultaneous determination of losartan and hydrochlorothiazide in tablets by high-performance liquid chromatographyPrevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del Retto[Isolation regional perfusion]
P50
Q33419448-12DFE53F-1E33-445C-B9DA-05B82E80B907Q36763755-206FCCBE-56C3-49C9-9E21-FB22C5C99E05Q42247140-91D57C43-AF47-4549-8C02-9DD9EE42FCEFQ42553666-6097BF5C-F42F-400C-B004-7E7CE8A09BF9Q42788699-2AFE728F-AE6F-4B49-953F-8155C76F093FQ43779508-8F6118C7-7AE1-436D-B08B-138D635897ABQ43789402-D76DE5D1-381B-4BA7-9352-98C12775379DQ43899253-F5AD1EA1-2080-4A97-837A-09C134C78AD5Q43907734-74BD5D8B-A9EA-4B90-A6D2-E58D37F8E37AQ46937657-95188491-CE2B-4959-955E-3F369D362A84Q47163375-9DC08BD6-6B0D-4372-8EBD-9A5C1EE7DC25Q50540693-3E40A741-B779-4DCC-B62D-D5C43DB40534Q52250147-8525745C-4BD4-4D8A-B581-7F9D4501F85DQ67553330-2C27C6D3-AF4C-4E90-A2C8-85B9110CB0B2Q67926757-C25A797E-3980-4D89-A0AD-4AB0DDD92D69Q68264225-3E870B36-91CC-4854-9A92-E4DA13E51DF0Q68348560-F3B8F508-C489-49AF-9E1E-9E57D3F1B5B8Q68504613-721B8897-66C8-4B29-A359-58281262AF12Q68856976-17C1ED6D-B75A-4572-8CD5-CD2A439D209FQ68856980-9A9D9DA7-7363-4911-AA5B-0C4529E81CB3Q70179982-216FBE48-BB14-4719-9996-C03C73FF5F55Q70617515-D9AE3A22-F4E5-4192-8F9B-850352771F0FQ70835094-CF79B786-3B77-4F6F-ADBC-DEA703F2EBBFQ71622249-CED0CF77-7EBD-497D-A705-1D8B29AF1C13Q73099388-6A44677F-71DB-4451-A8BA-17D2CB1C093AQ73099405-EC8307FA-17B3-4B3F-84B0-A8B3B1AC46C3Q73204666-51C04D0E-A0EA-483D-9879-B05831E1FD46Q73434510-C9BF0017-3630-4049-A9F4-BF11FD9619BDQ73938068-0273D483-2C75-46A5-AC40-6A302214ECA2Q73999701-BDE20F6E-4C55-4876-9F03-E3609C53C79CQ74012203-20483514-397E-4371-A5B5-5F563DBAA01CQ77417796-E30718CC-B4BE-49D3-913B-E649E37EB834Q78472587-532DEF27-9A92-4198-B1BF-1A2BA635A435
P50
description
researcher ORCID ID = 0000-0002-5464-7497
@en
name
Giancarlo Palumbo
@ast
Giancarlo Palumbo
@en
Giancarlo Palumbo
@es
Giancarlo Palumbo
@nl
type
label
Giancarlo Palumbo
@ast
Giancarlo Palumbo
@en
Giancarlo Palumbo
@es
Giancarlo Palumbo
@nl
prefLabel
Giancarlo Palumbo
@ast
Giancarlo Palumbo
@en
Giancarlo Palumbo
@es
Giancarlo Palumbo
@nl
P1153
7201792089
P21
P31
P496
0000-0002-5464-7497